Challenges of Artificial Heart Devices
Author:
Hsu Po-Lin,Wu Tingting
Publisher
Springer Singapore
Reference122 articles.
1. Vincentelli A, Susen S, Tourneau TL, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A, Jude B. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349:343–9. 2. Uriel N, Colombo PC, Cleveland JC, Long JW, Salerno C, Goldstein DJ, Patel CB, Ewald GA, Tatooles AJ, Silvestry SC, John R, Caldeira C, Jeevanandam V, Boyle AJ, Sundareswaran KS, Sood P, Mehra MR. Hemocompatibility-related outcomes in the momentum 3 trial at 6 months: a randomized controlled study of a fully magnetically levitated pump in advanced heart failure. Circulation. 2017;135(21):2003–12.
https://doi.org/10.1161/CIRCULATIONAHA.117.028303
. 3. Dionizovik-Dimanovski M, Levin AP, Fried J, Mody KP, Simonich E, Garan AR, Yuzefpolskaya M, Takayama H, Naka Y, Colombo PC, Kalesan B, Uriel N, Jorde UP. Correlation between home INR and core laboratory INR in patients supported with continuous-flow left ventricular assist devices. ASAIO J. 2015;61(4):386–90.
https://doi.org/10.1097/MAT.0000000000000229
. 4. Bishop MA, Streiff MB, Ensor CR, Tedford RJ, Russell SD, Ross PA. Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center. ASAIO J. 2014;60(2):193–8.
https://doi.org/10.1097/MAT.0000000000000047
. 5. Timms D. A review of clinical ventricular assist devices. Med Eng Phys. 2011;33(9):1041–7.
https://doi.org/10.1016/j.medengphy.2011.04.010
.
|
|